A 8824

  • New York Assembly Bill
  • 2021 Regular Session
  • Introduced in Assembly
  • Assembly
  • Senate
  • Governor

Enacts the manufacturer disclosure and transparency act

Abstract

Enacts the manufacturer disclosure and transparency act requiring prescription drug manufacturers to notify the attorney general of arrangements between pharmaceutical manufacturers resulting in the delay of the introduction of generic medications.

Bill Sponsors (1)

Votes


No votes to display

Actions


Jan 12, 2022

Assembly

REFERRED TO CONSUMER AFFAIRS AND PROTECTION

Bill Text

Bill Text Versions Format
A8824 PDF HTML

Related Documents

Document Format
No related documents.

Sources

Data on Open States is updated periodically throughout the day from the official website of the New York Legislature.

If you notice any inconsistencies with these official sources, feel free to file an issue.